This report brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions and help CMOs optimize operational and marketing strategies.
This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced drug product manufacturing.
In this Consumer Reports-style analysis, the research presents data on 524 service encounters from 134 respondents who have been involved in outsourced drug product projects in the past 18 months.
Drug Developers
Make a more educated purchase of CMO services by understanding which manufacturers best fit your company's needs in addition to how individual CMOs have measured up to sponsor-peer expectations on similar projects
Uncover which CMO attributes drive outsourcing partner selection for outsourced biologic drug product manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
Gain insight into CMO customer loyalty, an index based on customer satisfaction, willingness to recommend, and likelihood to use again, along with verbatim responses from customers regarding their experience
Contract Manufacturers
Understand your company's competitive positioning as well as delivery strengths and weaknesses and use this information to develop targeted messaging on true areas of strength
Compare your company's performance against its competitors across 23 performance metrics specific to outsourced drug product manufacturing and related services
Gain insight into drug developers' outsourcing preferences and practices with respect to CMO selection and CMO preference for outsourced biologic drug product manufacturing
Key Topics Covered
1. Outsourcing Philosophies and Practices
Primary Section Takeaways
Outsourced Manufacturing Activities
Outsourcing Drivers
Outsourcing Drivers by Company Size
Outsourcing Models
Preferred Providers
Number of Preferred Providers
2. CMO Selection Drivers
Primary Section Takeaways
Most Important CMO Attributes
CMO Attributes Gaining Importance
3. CMO Perceptions and Interactions
Primary Section Takeaways
CMO Familiarity
CMO Leaders - Unprompted
CMO Leaders - Prompted
Received Proposals
CMO Use
CMO Preference
CMO Preference Among Users
CMO Cost Perceptions
Summary Table
4. CMO Performance and Loyalty
Primary Section Takeaways
A Note on Performance Calculations
Performance Across Service Providers
Figure 1 - CMO Performance: Delivery Factors
Figure 2 - CMO Performance: Organization Factors
Figure 3 - CMO Performance: Capabilities Ratings
Figure 4 - CMO Performance: Staff Characteristics
Figure 5 - CMO Performance: Service Capabilities
CMO Loyalty
CMO Loyalty: 3-Year Rolling Average
5. Biologic Drug Product CMO Competitive Landscape
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients.
"It's critical for providers...
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...